Gregory Riedlinger

Rutgers Cancer Institute of New Jersey

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (6)

Antara Biswas

Rutgers Cancer Institute of New Jersey

UNITED STATES

View details

Subhajyoti De

UNITED STATES

View details

xiande Liu

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Ewa Gogola

University of Oxford

UNITED KINGDOM

View details

Nancy Davis

Associate Professor of Medicine & Urology

Vanderbilt University Medical Center

UNITED STATES

View details

Sven Rottenberg

University of Bern

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gregory Riedlinger

Research Interests

Explore related searches

Contact this professor

Articles (10)

Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Inference on spatial heterogeneity in tumor microenvironment using spatial transcriptomics data.

Truncated FGFR2 is a clinically actionable oncogene in multiple cancers.

Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an <i>N</i>-of-1 clinical trial.

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer.

Targetable alterations in invasive pleomorphic lobular carcinoma of the breast.

Weakly Supervised Deep Nuclei Segmentation Using Partial Points Annotation in Histopathology Images.

Collaborators (6)

Antara Biswas

Subhajyoti De

xiande Liu

Ewa Gogola

Nancy Davis

Sven Rottenberg

Make your next move.